Global T1D Research Map
Potential therapies and pathways towards a cure for type 1 diabetes. Cell technologies, immune protection, regeneration and other research directions.
SCIENCE TODAY. A BETTER TOMORROW.
Towards a future without type 1 diabetes.
A Sugar Pulse research initiative led by Bulat Valitov, PhD, an endocrinologist. We bring scientists, clinicians, researchers and the T1D community together to explore promising therapeutic approaches.
Our story, research programme and a direct line to the team
Centre documents: research map, evidence reviews and work plan →Artistic visualization of a cellular structure
Research and critical appraisal of evidence
Scientists, clinicians and people with T1D
Knowledge and collaboration across borders
More possibilities for people with T1D
RESEARCH PROGRAMME
Evidence reviews and the SP Science research programme. The global research map, a review of viral and immune factors in T1D, and the centre’s two-year work plan.
Potential therapies and pathways towards a cure for type 1 diabetes. Cell technologies, immune protection, regeneration and other research directions.
Enteroviruses, COVID-19, vaccination and antiviral defence. Evidence synthesis, five hypotheses and six proposed research projects.
From mapping the global landscape and consulting researchers to selecting projects, pilot studies, replication and funding.
ABOUT THE INITIATIVE
SP Science develops the research direction of Sugar Pulse, an international project. We connect scientific questions with the concerns that matter to people living with type 1 diabetes and their families.
Our next step is to build a research agenda and partnerships focused on promising therapeutic approaches.
Reviewing published evidence and exploring promising directions with experts.
Webinars, podcasts and research explained in accessible language.
Creating a space for dialogue among researchers, clinicians and people with T1D.

Endocrinologist
Leads the Sugar Pulse research initiative and contributes to expert discussions on type 1 diabetes and the development of its research agenda.
Professional profilePART OF SUGAR PULSE
OUR FOCUS
From understanding published evidence to meaningful discussions about the research that should come next.
Exploring published research on replacing insulin-producing cells, supporting their survival and restoring their function.
Evidence reviewFollowing research on autoimmunity in T1D and approaches intended to protect insulin-producing cells.
Evidence reviewExplaining research and discussing findings with scientists, while distinguishing evidence from unsupported promises.
Ongoing workDeveloping dialogue with researchers, clinicians and biotechnology teams to shape a shared research agenda.
Building partnershipsOUR APPROACH
Work with primary sources, examine study design and understand the limitations of reported results.
Bring scientists, clinicians, technology teams and the patient community into the same conversation.
Build the research agenda, partnerships and resources needed to take the work forward.
We are developing a research initiative and its scientific agenda. This website does not recruit participants for clinical trials or offer experimental treatment.
WATCH & READ
Meet the people, ideas and questions behind our work. Linked materials are currently in Russian.
PODCAST · YOUTUBE
A conversation with Bulat Valitov about type 1 diabetes research and the development of our scientific initiative.
Watch the conversationVIDEO · VK VIDEO
The Sugar Pulse video channel: expert discussions, educational content and life with diabetes.
Explore our videosARTICLE · RDA
Digital tools, patient navigation and science communication, presented on the Russian Diabetes Association website.
Read the articlePROGRESS THROUGH COLLABORATION
We welcome scientists, clinicians, researchers, biotechnology teams and partners interested in collaboration. People living with T1D and parents of children with diabetes are invited to follow our work and join the conversation.
Send your proposal through the website. We will reply by email.